• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于体外实验的合成实体化学结构、血小板聚集抑制效力与其细胞毒性之间的相互关系。

Interrelationships between the chemical structure of synthetic entities, their platelet aggregation inhibitory potency and their cellular toxicity, based on in vitro experiments.

作者信息

Lasslo A, Dillingham E O, McCastlain J C, Carter-Burks G, Quintana R P, Johnson R W, Naylor J L

出版信息

Med Prog Technol. 1986;11(3):109-21.

PMID:3796501
Abstract

Striking relationships were observed, in vitro, between the molecular constitution of synthetic entities, their aggregation-inhibitory potency (as determined in ADP-induced human blood platelet aggregation), and their cellular toxicity (as assessed by their inhibition of cultured mouse fibroblast L-cell growth). Effects exerted on platelets tended to reflect interactions between the molecules' aggregation-inhibitory specific functions and the platelets' corresponding target sites, while fibroblasts were generally more susceptible to the molecular constitution's hydrophobic character. The hyperbolic relationships between concentrations effecting 50% inhibition and slopes of concentration-response curves reflect net activity from both specific and nonspecific receptor site interactions, with the latter being dominant, and indicated that the assays approximated equilibrium systems. Plotting logarithm values of concentrations effecting 50% inhibition against logarithms of reciprocal slopes for concentration response curves yielded multiple regression coefficients of R = 0.97 (platelet aggregation-inhibitory potency) and R = 0.98 (fibroblast growth-inhibitory potency).

摘要

在体外实验中,观察到合成实体的分子组成、它们的聚集抑制效力(通过ADP诱导的人血小板聚集测定)以及它们的细胞毒性(通过对培养的小鼠成纤维细胞L-细胞生长的抑制评估)之间存在显著关系。对血小板产生的作用往往反映了分子聚集抑制特定功能与血小板相应靶位点之间的相互作用,而成纤维细胞通常对分子组成的疏水特性更敏感。影响50%抑制的浓度与浓度-反应曲线斜率之间的双曲线关系反映了特异性和非特异性受体位点相互作用的净活性,其中后者占主导地位,并表明这些测定近似于平衡系统。绘制影响50%抑制的浓度对数值与浓度反应曲线倒数斜率对数值的关系图,得到血小板聚集抑制效力的复相关系数R = 0.97和成纤维细胞生长抑制效力的复相关系数R = 0.98。

相似文献

1
Interrelationships between the chemical structure of synthetic entities, their platelet aggregation inhibitory potency and their cellular toxicity, based on in vitro experiments.基于体外实验的合成实体化学结构、血小板聚集抑制效力与其细胞毒性之间的相互关系。
Med Prog Technol. 1986;11(3):109-21.
2
Stereoselective inhibition of human platelet aggregation by R-138727, the active metabolite of CS-747 (prasugrel, LY640315), a novel P2Y12 receptor inhibitor.新型P2Y12受体抑制剂CS-747(普拉格雷,LY640315)的活性代谢产物R-138727对人血小板聚集的立体选择性抑制作用。
Thromb Haemost. 2005 Sep;94(3):593-8. doi: 10.1160/TH05-03-0208.
3
The effect of carbamoylpiperidine and nipecotoylpiperazine analogs on ADP-stimulated human thrombocyte aggregation and platelet factor 3 availability.氨甲酰哌啶和哌嗪甲酰哌啶类似物对二磷酸腺苷刺激的人血小板聚集及血小板因子3有效性的影响。
Res Commun Chem Pathol Pharmacol. 1990 Feb;67(2):179-99.
4
Serotonin efflux-inducing effects on human blood platelets by carbamoylpiperidine and nipecotoylpiperazine aggregation inhibitors.氨甲酰哌啶和琥珀酰哌嗪聚集抑制剂对人血小板的5-羟色胺流出诱导作用。
Res Commun Chem Pathol Pharmacol. 1987 Oct;58(1):129-37.
5
Relationships between the chemical constitution of aggregation inhibitors and human blood platelet response profile.聚集抑制剂的化学组成与人体血小板反应特征之间的关系。
Biochim Biophys Acta. 1984 Apr 25;772(1):84-92. doi: 10.1016/0005-2736(84)90520-0.
6
Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.新型P2Y12受体抑制剂普拉格雷的重复口服给药在几种动物物种中导致累积且强效的抗血小板和抗血栓形成活性。
Eur J Pharmacol. 2008 Jan 28;579(1-3):276-82. doi: 10.1016/j.ejphar.2007.10.005. Epub 2007 Oct 11.
7
In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.强效血小板活化因子(PAF)受体拮抗剂SR 27417对PAF诱导的牛血小板聚集的体外抑制作用。
Vet Res. 2000 Mar-Apr;31(2):267-72. doi: 10.1051/vetres:2000115.
8
Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.在评估血小板ADP P2Y12受体抑制作用时,VASP磷酸化检测与光透射聚集法的比较。
Thromb Haemost. 2006 Dec;96(6):767-73.
9
Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.用于阿尔茨海默病治疗的具有双重抑制乙酰胆碱酯酶和β淀粉样蛋白1-42聚集活性的新型哌啶衍生物的合成、体外测定及分子模拟
Bioorg Med Chem. 2007 Oct 15;15(20):6596-607. doi: 10.1016/j.bmc.2007.07.003. Epub 2007 Jul 25.
10
Inhibition of agonist-induced rise in platelet Ca2+ by antithrombotic nipecotamides.
Blood Coagul Fibrinolysis. 1994 Jun;5(3):375-83.

引用本文的文献

1
Stereocontrolled synthesis of 3-hydroxy-2-piperidinone carboxamides by catalytic ring-opening aminolysis of bridged -lactam-γ-lactones.通过桥连β-内酰胺-γ-内酯的催化开环氨解反应立体控制合成3-羟基-2-哌啶酮羧酰胺
RSC Adv. 2025 May 14;15(20):16028-16034. doi: 10.1039/d5ra02161h. eCollection 2025 May 12.